A decreasing trend was also observed in Stage IV disease, although this trend did not reach statistical significance (p = 0.32), possibly because of the limited sample size (Fig. 2 D).
← all excerpts
Exploratory multiomics analysis identifies WDR17 as a potential biomarker of tyrosine kinase inhibitor resistance in lung adenocarcinoma.
1
—
—